Clinical Trials Directory

Trials / Completed

CompletedNCT01180842

Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF)

Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With CF

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Children's Hospitals and Clinics of Minnesota · Academic / Other
Sex
All
Age
9 Years – 18 Years
Healthy volunteers
Accepted

Summary

The investigators research question is whether or not yoga effectively alleviates symptoms of pain, sleep disturbance, anxiety and depression in children with cystic fibrosis. If yoga does prove to be effective, the investigators will educate our CF population about the benefits they may experience if they choose to incorporate yoga into their CF therapy. The investigators will also go on to do further research of other complementary alternative medicine therapies. This is a pre/post-test study with 20 subjects. The subjects will serve as their own controls. Each subject will participate in six yoga sessions over a ten week period. Subjects' symptoms will be evaluated with the use of questionnaires. The investigators will also test cortisol levels on weeks -2, -1, 1, 6, 7, 8. Cortisol is a hormone that is affected by stress. Testing of cortisol throughout the study will help us determine the subjects' stress level throughout the study.

Detailed description

H1: The implementation of a yoga therapy program decreases symptoms of pain within our CF population. H2: The implementation of a yoga therapy program decreases symptoms of sleep disturbance within our CF population. H3: The implementation of a yoga therapy program decreases symptoms of anxiety within our CF population. H4: The implementation of a yoga therapy program decreases symptoms of depression within our CF population.

Conditions

Interventions

TypeNameDescription
OTHERYoga treatment programyoga program designed specifically for the patient with CF

Timeline

Start date
2010-03-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2010-08-12
Last updated
2014-02-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01180842. Inclusion in this directory is not an endorsement.